| 摘要 |
<p>The present invention relates to compounds of the formula (I), pharmaceutical compositions containing said compounds, methods for the preparation thereof, and methods for their use. The compounds are useful in treating diseases characterized by the hyperactivity of MEK. Accordingly the compounds are useful in the treatment of diseases, such as cancer, cognitive and CNS disorders, and inflammatory/autoimmune diseases.</p> |
| 申请人 |
F. HOFFMANN-LA ROCHE AG;CHEN, SHAOQING;HUBY, NICHOLAS JOHN SILVESTER;KONG, NORMAN;MISCHKE, STEVEN GREGORY;MOLITERNI, JOHN ANTHONY;WANG, HONG;ZHANG, ZHUMING |
发明人 |
CHEN, SHAOQING;HUBY, NICHOLAS JOHN SILVESTER;KONG, NORMAN;MISCHKE, STEVEN GREGORY;MOLITERNI, JOHN ANTHONY;WANG, HONG;ZHANG, ZHUMING |
